Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles

International Heart Journal

Volumn 49, Issue 6, 2008, Pages 723-732

  Konno, Yuusuke ^a   Kimura, Kenjiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cilnidipine; Efferent arterioles; Hydronephrotic kidney model; N type calcium channel; Omega conotoxin

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE BLOCKING AGENT; CALCIUM CHANNEL N TYPE BLOCKING AGENT; CILNIDIPINE; NIFEDIPINE; OMEGA CONOTOXIN; UNCLASSIFIED DRUG; DIHYDROPYRIDINE DERIVATIVE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; EX VIVO STUDY; FEMALE; GLOMERULUS CAPILLARY; HYDRONEPHROSIS; HYPERTENSION; KIDNEY BLOOD FLOW; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASODILATATION; ANIMAL; ARTERIOLE; BLOOD PRESSURE; DRUG EFFECT; GLOMERULUS; PATHOPHYSIOLOGY; VASCULARIZATION;

ANIMALS; ARTERIOLES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYDRONEPHROSIS; KIDNEY GLOMERULUS; NIFEDIPINE; OMEGA-CONOTOXINS; RATS; RATS, INBRED SHR; VASODILATOR AGENTS;

EID: 60249083404     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.723     Document Type: Article

References (35)

1. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-8.
2. Kimura G. Glomerular function reserve and sodium sensitivity. Clin Exp Nephrol 2005; 9: 102-13. (Review)
3. Konishi Y, Imanishi M, Okamura M, et al. Relationship of renal histological damage to glomerular hypertension in patients with immunoglobulin A nephropathy. J Hypertens 2000; 18: 103-9.
4. Ofstad J, Horvei G, Kvam FI, et al. Glomerular hemodynamics in progressive renal disease. Kidney Int Suppl 1992; 36: S8-14. (Review)
5. Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int 1993; 43: 808-14.
6. Anderson S, Rennke HG, Brenner BM. Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int 1992; 41: 891-7.
7. Kimura K, Tojo A, Hirata Y, Hayakawa H, Goto A, Omata M. Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles. Blood Press Suppl 1994; 5: 71-4.
8. Tojo A, Kimura K, Matsuoka H, Sugimoto T. Effects of manidipine hydrochloride on the renal microcirculation in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1992; 20: 895-9.
9. Saruta T, Kanno Y, Hayashi K, Konishi K. Antihypertensive agents and renal protection: calcium channel blockers. Kidney Int Suppl 1996; 55: S52-6.
10. Fujii S, Kameyama K, Hosono M, Hayashi Y, Kitamura K. Effect of cilnidipine, a novel dihydropyridine Ca++-channel antagonist, on N-type Ca++ channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 1997; 280: 1184-91.
11. Uneyama H, Takahara A, Dohmoto H, Yoshimoto R, Inoue K, Akaike N. Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones. Br J Pharmacol 1997; 122: 37-42.
12. Uneyama H, Uchida H, Yoshimoto R, Ueno S, Inoue K, Akaike N. Effects of a novel antihypertensive drug, cilnidipine, on catecholamine secretion from differentiated PC12 cells. Hypertension 1998; 31: 1195-9.
13. Oike M, Inoue Y, Kitamura K, Kuriyama H. Dual action of FRC8653, a novel dihydropyridine derivative, on the Ba2+ current recorded from the rabbit basilar artery. Circ Res 1990; 67: 993-1006.
14. Hirning LD, Fox AP, McCleskey EW, et al. Dominant role of N-type Ca2+ channels in evoked release of nore-pinephrine from sympathetic neurons. Science 1988; 239: 57-61.
15. Pruneau D, Angus JA. Omega-conotoxin GVIA is a potent inhibitor of sympathetic neurogenic responses in rat small mesenteric arteries. Br J Pharmacol 1990; 100: 180-4.
16. Clasbrummel B, Osswald H, Illes P. Inhibition of noradrenaline release by omega-conotoxin GVIA in the rat tail artery. Br J Pharmacol 1989; 96: 101-10.
17. Steinhausen M, Ballantyne D, Fretschner M, Hoffend J, Parekh N. Different responses of cortical and juxtamedullary arterioles to norepinephrine and angiotensin II. Kidney Int Suppl 1990; 30: S55-9.
18. Hosono M, Fujii S, Hiruma T, et al. Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jpn J Pharmacol 1995; 69: 127-34.
19. Dieterich HJ. Electron microscopic studies of the innervation of the rat kidney. Z Anat Entwicklungsgesch 1974; 145: 169-86.
20. Barajas L, Powers K. Monoaminergic innervation of the rat kidney: a quantitative study. Am J Physiol 1990; 259: F503-11.
21. Kimura K, Inokuchi S, Sugaya T, et al. Location and action of angiotensin II type 1 receptor in the renal micro-circulation. Kidney Int Suppl 1997; 63: S201-4.
22. Kimura K, Suzuki N, Kamijo A, et al. Differential effects of the calcium channel blocker nifedipine on renal microcirculation: A comparative study using hydronephrotic rats. Curr Ther Res 2000; 61: 367-75.
23. Kimura K, Suzuki N, Ohba S, et al. Effects of amlodipine, a calcium channel blocker, on rat renal arterioles. Curr Ther Res 1997; 58: 375-80.
24. Epstein M. Calcium antagonists and the kidney: implications for renal protection. Kidney Int Suppl 1992; 36: S66-72. (Review)
25. Kimura K, Suzuki N, Mise N, et al. Effects of barnidipine hydrochloride, a calcium channel blocker, on renal microcirculation in rats: a pilot study. Curr Ther Res 1998; 59: 826-34.
26. Kon V. Neural control of renal circulation. Miner Electrolyte Metab 1989; 15: 33-43. (Review)
27. Sakaki T, Naruse H, Masai M, et al. Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts. Ann Nucl Med 2003; 17: 321-6.
28. Takahara A, Koganei H, Takeda T, Iwata S. Antisympathetic and hemodynamic property of a dual L/N-type Ca(2+) channel blocker cilnidipine in rats. Eur J Pharmacol 2002; 434: 43-7.
29. Protasoni G, Golin R, Genovesi S, Zanchetti A, Stella A. Functional evidence of inhibitory reno-renal reflexes in spontaneously hypertensive rats. Blood Press 1996; 5: 305-11.
30. Arima S, Ito S, Omata K, Tsunoda K, Yaoita H, Abe K. Diverse effects of calcium antagonists on glomerular hemodynamics. Kidney Int Suppl 1996; 55: S132-4.
31. Yuan BH, Robinette JB, Conger JD. Effect of angiotensin II and norepinephrine on isolated rat afferent and efferent arterioles. Am J Physiol 1990; 258: F741-50.
32. Takahara A, Dohmoto H, Hisa H, Satoh S, Yoshimoto R. Cilnidipine attenuates renal nerve stimulation-induced renal vasoconstriction and antinatriuresis in anesthetized dogs. Jpn J Pharmacol 1997; 75: 27-32.
33. el-Din MM, Malik KU. Differential effect of omega-conotoxin on release of the adrenergic transmitter and the vasoconstrictor response to noradrenaline in the rat isolated kidney. Br J Pharmacol 1988; 94: 355-62.
34. Satonaka H, Suzuki E, Hayakawa H, et al. Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis. Int Heart J 2005; 46: 701-10.
35. Fujita T, Ando K, Nishimura H, et al. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int 2007; 72: 1543-9.